Compare Neurocrine Biosciences Inc (NBIX) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Oscar Health Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Oscar Health Inc trades at $30.77 (market cap $8.92B). The key difference: Neurocrine Biosciences Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| NBIX | OSCR | |
|---|---|---|
Market Cap | $17.40B | $8.92B |
Sector | Health | Health |
52-Week High | $180.55 | $32.18 |
52-Week Low | $123.10 | $10.85 |
Enterprise Value | $16.49B | $4.55B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
